Clinical Trial Update: Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET [NA]

View source ↗

Summary

This clinical trial update describes a study characterizing metabolism in Alzheimer's disease and frontotemporal dementia using 23Na‑MRI and FDG‑PET imaging bef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Frontotemporal Dementia

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: FTD, AD | NA | Status: NOT_YET_RECRUITING